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Abstract 






) on Escherichia coli expressing either prion (hPrP
C 
) or 
metallothionein 3 (MT-3) brain proteins capable of binding these metals were investigated. The expression 
of hPrP
C 
or MT-3 in E.coli was confirmed using western-blot and dot-blot methods. After analyzing growth 
curves, we found that bacteria expressing prion protein better tolerated the presence of Zn
2+
 in comparison 




 was well tolerated by 
bacteria expressing MT-3, whereas the bacteria expressing prion protein displayed slower growth when 
compared to the wild-type. We subsequently determined total content of the MT in bacteria using 
differential pulsed voltammetry (DPV), and depending on the treatment of the individual metals. MT 
expression in MT3 transformed cells as well as in control E.coli cells increased at the lowest metal 
concentration (25 µM), followed by a decrease at higher metal concentrations (50, 75, and 150 µM). The 
highest increase by Cd
2+
 were observed.  MT expression pattern in hPrP
C
 transformed cells was different. 
After application of Cu
2+ 
an increase in MT expression continued also at higher metal concentrations; and 









; PrPSc; MT; MT-3; copper; zinc; cadmium. 
 
Introduction 
Numerous studies suggest that prion disease is caused by conformational conversion of PrPC (the 
normal cellular prion protein) to PrPSc (its abnormal isoform), which becomes infectious [1]. In 1982, 
Stanley B. Prusiner formulated Prion theory, recognizing the substance of which was the definition of the 
prion protein infectious particle that lacks nucleic acid [2]. PrP is encoded by a single copy of chromosomal 
gene [3]. The gene encoding PrP (PRNP) is a copy of the gene that is located on the 20th chromosome in 
humans [4]. Prion protein (PrPC) is a protein naturally present in all mammalian cells. Cellular prion protein 
(PrPC, Fig. 1A) is a glycoprotein that is located primarily in the central nervous system (CNS), but also occurs 
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in smaller quantities in other tissues. The physiological function of this protein is not yet fully understood, 
but it is probably involved in cell differentiation and synaptic transmission [5]. Posttranslational 
modifications of PrPC and conformational changes to pathological isoform PrPSc are the molecular basis of 
prion diseases [6]. In comparison with the knowledge about PrP
C





, Fig. 1B) is highly resistant to degradation processes in the cells and, upon 
binding to PrP
C
 proteins these isoforms will change the original conformation to the conformation of PrP
Sc
. 
The presence of hardly degradable protein and lack of physiological PrP
C
 therefore will lead to the 
emergence and development of progressive neurodegenerative diseases known as transmissible 
spongiform encephalopathy (TSE), which are clinically heterogeneous and currently incurable [7-9]. These 
illnesses - in humans and animals - include the following diseases: Creutzfeldt-Jakob disease (CJD) or 
Gertsman-Straussler-Schenker syndrome in humans, scrapie in both sheep and goats, and bovine 
spongiform encephalopathy (BSE) in cows. [10-12]. Experiments with tissue culture of cerebellum showed 
that cells lacking PrP
C
 are more susceptible to oxidative stress and readily undergo cell death [13]. Some of 









Figure 1. (A) Scheme of the structure of cellular form of prion protein (PrPC). (B) The 
structure of pathological (abnormal) prion protein (PrPSc). Adapted from [2]. 
Because the PrPC is a metal binding protein, there is a hypothesis that the metal ions (Cu2+, Zn2+ and 
Mn2+) can play a role in the transformation of PrPC to PrPSc. Equally important link between prion diseases 
and metals is a protein called metallothionein. The brain specific form of metallothionein-3 (MT-3) ensures 
the maintenance of optimal concentrations of metals in the brain. Also the involvement of MT-3 in the 
formation of neurodegenerative diseases was observed as the decrease in the MT-3 levels led to the 
formation of neurofibrillary clusters characteristic for neurodegenerative diseases [20-22].The aim of this 
study was to monitor heavy metal ions influence on the growth and electrochemical properties of E. coli 
strains transformed with PrPC or MT-3 protein. 
Experimental  
Chemicals, preparation of deionized water and pH measurement 
Chemicals used in this study were purchased from Sigma-Aldrich (St. Louis, MO, USA) in American 
Chemical Society (ACS) purity unless noted otherwise. The deionized water was prepared using reverse 
A B 
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osmosis equipment Aqual 25 (Aqual s.r.o., Brno, Czech Republic). The deionized water was further purified 
at 18 MΩ resistance using MiliQ Direct QUV equipped with UV lamp. The pH was measured using pH meter 
WTW inoLab (Weilheim, Germany). 
Chemical transformation, growth conditions and isolation of protein fraction  
The Human MT-3 protein (hMT-3) and human prion protein (hPrP
C
) were cloned in the pRSET-B vector 
(Invitrogen, USA). High levels of expression of DNA sequences cloned into the pRSET vectors were made 
possible by the presence of the T7 promoter. The chemical transformation protocol was performed 
following the instructions of New England Biolabs, using as host BL21 (DE3) pLysS chemically competent E. 
coli strain. Bacteria transformed with pRSET-hMT-3 or pRSET-hPrP
c
 plasmid were selected by ampicillin 
resistance. The positive transformants were confirmed by PCR screening. 
The positive transformants were grown in LB (Luria Bertani) medium (10 g tryptone, 5 g yeast extract, 5 
g NaCl) with 50 µg mL-1 ampicillin and 35 µg mL-1 chloramphenicol shaking at 37 °C overnight. The next day, 
each culture was grown to 0.1 of OD600nm. When the culture reached the exponential phase (0.4 - 0.6), IPTG 
(isopropylthio-b-D-galactopyranoside) was added to a final concentration of 1 mM and the cells were 
allowed to grow for 4 to 6 hours. After centrifugation at 4000 rpm for 10 min, the pellet was resuspended, 
with 20 mM phosphate buffer at neutral pH and frozen in liquid nitrogen. The frozen lysate was thawed at 
42 °C (this freeze-thaw action was repeated three times). The protein fraction was harvested by 
centrifugation at 4000 rpm for 10 minutes at 4 °C. 
Measurement of growth curves after addition of selected heavy metal ions (Cu2+, Zn2+ and Cd2+) to the 
bacterial cultures 
Procedure for the evaluation of the antimicrobial effect of tested compounds and their combinations 
consisted of measuring the absorbance using the apparatus Multiscan EX (Thermo Fisher Scientific, 
Germany) and subsequent analysis in the form of growth curves. Control bacterial cultures of E. coli and E. 
coli with hMT-3 or hPrP
C
 were cultivated in LB medium with 50 µg mL
-1
 ampicillin, 35 µg mL
-1 
chloramphenicol and 1 mM IPTG for 24 hours with shaking. In the microplate these cultures were mixed 
with cadmium, zinc and copper ions (10, 50, 150 and 300 µM concentrations) or strains without addition of 
heavy metal ions alone as a control for measurements. Total volume in the microplate wells was always 
300 µL. Measurements were carried out at time 0, then each half-hourly for 24 hours at 37 °C and 
a wavelength of 620 nm. 
Preparation of samples 
Each sample (control strains – E. coli, E. coli – MT-3, E. coli - hPrPC or strains with addition of 10, 25, 50, 
75, 150 and 300 µM concentrations of Cu2+, Zn2+ and Cd2+ ions) was centrifuged at 8000 rpm for 
10 minutes. Liquid nitrogen was added to the pellet. After evaporation, 1 mL of phosphate buffer (pH 7) 
was added and samples were mixed for 30 minutes. Two minutes of ultrasound were used for the lysis of 
cells. After centrifugation at 8000 rpm for 10 minutes, the supernatant was used in the following 
experiments. For electrochemical measurements 25, 50, 75, and 150 µM of metal ions were used. 
Electrochemical measurement of metallothionein by differential pulse voltammetry 
Differential pulse voltammetric measurements were performed with 747 VA Stand instrument 
connected to 693 VA Processor and 695 Autosampler (Metrohm, Switzerland), using a standard cell with 
three electrodes, a cooled sample holder, and measurement cell cooled to 4 °C (Julabo F25, Germany). A 
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hanging mercury drop electrode (HMDE) with a drop area of 0.4 mm
2
 was the working electrode. An 
Ag/AgCl/3M KCl electrode was the reference and platinum electrode was auxiliary. For data processing VA 
Database 2.2 by Metrohm CH was employed. The analysed samples were deoxygenated prior to 
measurements by purging with argon (99.999 %) saturated with water for 120 s. Brdička supporting 
electrolyte containing 1mM Co(NH3)6Cl3 and 1M ammonia buffer (NH3(aq) + NH4Cl, pH = 9.6) was used. The 
supporting electrolyte was exchanged after each analysis. The parameters of the measurement were as 
follows: initial potential of -0.700 V, end potential of -1.750 V, modulation time 0.057 s, time interval 0.2 s, 
step potential 0.002 V, modulation amplitude -0.250 V, Eads = 0 V, volume of injected sample: 20 µl, 
volume of measurement cell 2 ml (20 μl of sample and 1980 µl Brdicka solution) for calibration curves. For 
calibration curve measurements MT2A standard (Ikzus Proteomics, Italy) was used. The volume for the 
measurement of bacterial culture of E. coli and E. coli with MT-3 or hPrPC with metals was 100 µl of 
bacterial culture and 1900 µl of Brdicka solution. 
Statistical analyses  
Software STATISTICA (data analysis software system) version 10.0 (Tulsa, Oklahoma, USA) was used for 
data processing. Half-maximal concentrations (IC50) were calculated from logarithmic regression of 
sigmoidal dose-response curve. General regression model was used to analyse differences between the 
combinations of compounds. To reveal the differences between cell lines, Tukey’s post hoc test within 
homogenous groups and also F-test was employed. Unless noted otherwise, p < 0.05 was considered 
significant. Data from 3 measurements were analysed. 
Results and Discussion 
The aim of this study was to determine the effect of copper, zinc and cadmium ions on metallothionein 
level and on the growth of two different E. coli bacterial cultures transformed with the plasmid containing 
hPrP
C 
or MT-3 gene, and control  E. coli (BL21(DE3)) strain. Proteins PrP
C 
and MT-3 are able to bind heavy 
metals, thus protecting cells from their toxicity and we attempted to test this hypothesis by the mentioned 
experiments. 
Verification of the expression of recombinant human prion protein (hPrPC) and metallothionein 3 (MT-3) 
using western-blot 
The presence of the hPrPC expression was verified using western-blot (Fig. 2). To achieve better 
production and stimulation of proteins in bacterial cells IPTG (Isopropyl β-D-1-thiogalactopyranoside) was 
added to culture. Bacterial cells, which were expressing hPrPC protein, were divided into pellet and 
supernatant after lysis and subsequent centrifugation. After electrophoretic separation by SDS-PAGE (Fig. 
2A), the proteins were transferred to a nylon membrane where they were detected with antibodies against 
hPrPC protein. Positive band of hPrPC protein with size of about 20 kDa was detected in the pellet of 
bacterial cells in a sample with the addition of IPTG only. This finding can be explained by possible 
aggregation and crystallization of hPrPC in pellet (Fig. 2B). These results were also confirmed by dot-blot 
(not shown). 
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Figure 2. Verification of the prion protein (hPrPC) presence in E. coli BL21(DE3) cells  transformed with a 
plasmid containing hPrPC gene. Red ellipse indicates occurrence of prion protein (size 20-23 kDa). (A) Gel 
stained with Coomassie brilliant blue, standard: Precision Plus Protein Dual Xtra Standards (Bio-Rad); (B) 
Western blot, standard: Precision Plus Protein Dual Xtra Standards (Bio-Rad) Mr-molecular mass standard. For 
both (A and B), lane 1: hPrPC supernatant, lane 2:  hPrPC pellet, lane 3: hPrPC /+IPTG supernatant, lane 4:  
hPrPC /+IPTG pellet. 
In the same way, the presence of MT-3 protein expression was verified (Fig. 3A). Using western-blot a 
positive band with a size of about 10 kDa in both cell fractions (supernatant and pellet) supplemented with 
IPTG was verified (Fig. 3B). The same results were achieved also by dot-blot method (not shown). 
 
 
Figure 3. Verification of the metallothionein (MT-3) presence in E. coli BL21(DE3) cells  transformed with a 
plasmid containing MT-3 gene. Red ellipses indicate occurrence of metallothionein 3 protein (size 7-10 kDa). 
(A) Gel stained with Coomassie brilliant blue, standard: Precision Plus Protein Dual Xtra Standards (Bio-Rad); 
(B) Western blot, standard: Precision Plus Protein Dual Xtra Standards (Bio-Rad), Mr-molecular mass 
standard. For both (A and B), lane 1 E. coli BL21(DE3) supernatant, lane 2: E. coli BL21(DE3)  pellet, lane 3: 
MT-3 supernatant, lane 4: MT-3 pellet, lane 5: MT-3/+IPTG  supernatant, lane 6: MT-3/+IPTG  pellet. 
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) on growth of bacterial cultures expressing  hPrP
C
 or MT-3 
proteins 
An effect of copper, zinc and cadmium ions on growth of bacterial cultures expressing hPrP
C
 or MT-3 
proteins was investigated by growth curve method. The procedure for evaluating antimicrobial activity of 
three chosen heavy metals (Cu2+, Zn2+ and Cd2+) was based on measuring the absorbance of transformed 
bacterial cultures of E. coli expressing the hPrP
C
 and MT-3 proteins compared to control bacterial E. coli 
BL21(DE3) culture, which was also exposed to the action of mentioned heavy metals. Figure 4 shows the 






) on the proliferation of transformed bacterial cultures expressing 
hPrP
C
 or MT-3 genes. 
          
Figure 4. Spectrophotometric determination of growth curves obtained after treatment of  E. coli BL21 cells 
transformed with an empty plasmid (a), plasmid containing hPrP
C
 gene (b) or MT-3 gene (c) with 0, 10, 50, 
150 and 300 μM concentration of metal ions Cd (A), Cu (B) and Zn (C). Average values IC 50 (50 % inhibitory 
concentration) calculated from all growth curves are given. Data represent mean calculated from 3 
measurements. 
Cells, which expressed MT-3 protein and were exposed to the increasing concentration of cadmium 
ions, exhibited more effective protection against toxic effects induced by cadmium(II) (IC 50 = 90.1  μM) 
than cells expressing hPrPC protein (IC 50 =11.2 μM) (Figs. 4A-a,b, c).   On the other hand, the application of 
ADMET & DMPK 3(3) (2015) 287-295 Prion interactions with metals and metallothionein 
doi: 10.5599/admet.3.3.191 293 
copper(II) ions caused on the cells expressing hPrP
C
 higher inhibition of growth (IC 50 = 2.7 μM) and growth 
was decreased by 46 % in presence of 300 µM concentration of copper (Figs. 4B-a;b). The concentration 
required for growth inhibition of 50 % of cells was measured on 5.1 µM and the highest used concentration 
of copper (II) caused 56 % growth inhibition of cells (Fig. 4B-a). The best protection against copper (II) 
toxicity showed cells expressing MT-3 (IC 50 = 10.0 μM) with 37 % inhibition of bacterial growth (Fig. 4B-c).  
Similar findings as in the presence of cadmium (II) ions were also observed in the case of zinc (II) ions. 
The cells expressing hPrP
C 
protein were exposed to the increasing concentration of zinc(II) ions. The best 
protection against toxicity of metals was observed after addition of zinc (II) ions (IC 50 = 520.8 μM), as it is 
shown in Figs. 4C-a,b. These bacterial cultures were inhibited by treatment with zinc (II) ions. The cells 
expressing MT-3 (IC 50 = 46.9 μM, Figs. 4C-c) were less protected (25 % inhibition of bacterial growth in 
presence of 300 μM concentration of zinc (II) and the least protected were the control cells 
(IC 50 = 5.0 μM, Fig. 4C-a). The control cells were inhibited by up of 69 % after addition of the same 
concentration of zinc (II) ions. 
Electrochemical determination of the total MT level after addition of metal ions (Cu2+, Zn2+ and Cd2+) to the 
bacterial cultures expressing hPrPC or MT-3 proteins 
Before the measurement of total MT level, a calibration curve (Fig. 5A) was determined by measuring 
different concentrations of MT 2A standard (0.39 – 25.0 μg/ml), whereas DP voltammograms are shown in 
Fig. 5B. Catalytic signal Cat2 measured at the potential of -1.56 V linearly corresponded to the 
concentration of metallothionein. MT values obtained by reading from the calibration curve were 
recalculated to mg of protein determined in the sample.  
 
 
Figure 5. (A) Calibration curve of total MT determined using DPV method, as electrolyte Brdicka solution was 
used (1 mM Co(NH3)6Cl3 and 1 M ammonium buffer (NH3(aq) and NH4Cl, pH = 9.6)). Experimental parameters 
were chosen as follows: initial potential -0.4 V, end potential -1.75 V, modulation time 0.057 s, time interval 
0.2 s, step potential 2 mV, and modulation amplitude 250 mV. (B) DP voltammograms of MT standards (0.39 - 
25 µg/ml) obtained from the calibration curve. 
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Further, DPV measurements of the total MT level in the control E. coli cells and in E. coli cells expressing 
hPrP
C
 or MT-3 proteins were performed. These cultures were exposed to the increasing concentration of 
two essential metal ions (Cu2+ and Zn2+) and one toxic metal ion (Cd2+). Bacteria that expressed MT-3 
protein, had slightly higher MT levels after application of increasing metal concentrations (25, 50, 75 and 
150 µM) in comparison with control cells with similar pattern (Fig. 6). MT expression increased at lowest 
metal concentration (25 µM), followed by a decrease at higher metal concentrations (50, 75, and 150 µM). 
The highest increase in MT levels in bacterial cells after application of Cd
2+
 were observed followed by cells 
with addition of Zn
2+
. The smallest increases in MT levels were observed in cells with addition of Cu
2+
. MT 
expression pattern in hPrPC transformed cells was different. After application of Cu2+ an increase in MT 
expression continued also at higher metal concentrations; and after application of Cd2+ and Zn2+ no 
decrease in MT expression at higher metal concentrations was observed.  
 
 
Figure 6.  Metallothionein content in E. coli cells BL21 transformed with an empty plasmid, the plasmid 
containing hPrP
C
 or MT-3 gene after incubation with different concentrations of (A) Cu, (B) Zn and (C) Cd in 
concentrations of 25, 50, 75, and 150 μM compared to control cells without addition of metal. Data represent 
mean ± s.d. calculated from 3 measurements, NS, not significant, *P < 0.05. 
Conclusions 
Clarifying the precise function of MT-3 and the conversion of the prion protein into its pathological form 
would contribute to a better understanding of the emergence of transmissible spongiform 
encephalopathies and the development of effective drugs to cure them. The first step for research of brain 
protein functions is the use of a bacterial model, where it is possible to observe the effect of metals on 
growth of bacterial cells, in which the brain proteins are produced. Another interesting topic is the 
monitoring of interconnection between functions of prion protein and MT-3.   
In this work the presence of both hPrPC and MT-3 protein expression in bacterial cells was verified using 
western-blot and dot-blot. Furthermore, by the growth curve measurement and electrochemical 
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  MT-3 protein was 






. The  
different situation occurred in the case of addition of Cu2+, when the MT-3 was equally effective as hPrPC, 
whose expression even increased the inhibitory effect of copper ions on the growth of bacterial cells.  
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